These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 25266957

  • 1. MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1.
    Wu H, Liu Q, Cai T, Chen YD, Liao F, Wang ZF.
    Diagn Pathol; 2014 Sep 30; 9():173. PubMed ID: 25266957
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms for hypoxia-induced long non-coding small nucleolar RNA host gene 14 in promoting temozolomide resistance of glioma.
    Zhao H, Meng L, Liao X, Liu Y, Mo X, Gong M, Liao Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul 28; 47(7):829-838. PubMed ID: 36039578
    [Abstract] [Full Text] [Related]

  • 3. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
    Wei J, Qi X, Zhan Q, Zhou D, Yan Q, Wang Y, Mo L, Wan Y, Xie D, Xie J, Yang S.
    Biomed Pharmacother; 2015 Apr 28; 71():112-8. PubMed ID: 25960225
    [Abstract] [Full Text] [Related]

  • 4. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D, Wan Y, Xie D, Wang Y, Wei J, Yan Q, Lu P, Mo L, Xie J, Yang S, Qi X.
    Exp Mol Med; 2015 Sep 04; 47(9):e182. PubMed ID: 26337869
    [Abstract] [Full Text] [Related]

  • 5. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
    Han J, Chen Q.
    Int J Clin Exp Pathol; 2015 Sep 04; 8(10):12698-707. PubMed ID: 26722459
    [Abstract] [Full Text] [Related]

  • 6. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24.
    Chen M, Cheng Y, Yuan Z, Wang F, Yang L, Zhao H.
    Cancer Biother Radiopharm; 2020 Mar 04; 35(2):101-108. PubMed ID: 31750728
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX, Yang Y, Zhang X, Luan XP.
    Eur Rev Med Pharmacol Sci; 2020 Feb 04; 24(4):1922-1931. PubMed ID: 32141561
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C, Shen F, Du J, Fang X, Li X, Su J, Wang X, Huang X, Liu Z.
    Biomed Pharmacother; 2018 Jan 04; 97():844-850. PubMed ID: 29136760
    [Abstract] [Full Text] [Related]

  • 9. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
    Wang J, Sai K, Chen FR, Chen ZP.
    Cancer Chemother Pharmacol; 2013 Jul 04; 72(1):147-58. PubMed ID: 23645289
    [Abstract] [Full Text] [Related]

  • 10. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C, Feng S, Chen L.
    Mol Cell Biochem; 2021 Feb 04; 476(2):699-713. PubMed ID: 33106913
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
    Tang JH, Ma ZX, Huang GH, Xu QF, Xiang Y, Li N, Sidlauskas K, Zhang EE, Lv SQ.
    Exp Cell Res; 2016 May 01; 343(2):148-158. PubMed ID: 27090014
    [Abstract] [Full Text] [Related]

  • 12. LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway.
    Du P, Zhao H, Peng R, Liu Q, Yuan J, Peng G, Liao Y.
    Biosci Rep; 2017 Oct 31; 37(5):. PubMed ID: 28831025
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of microRNA-216b contributes to glioma cell growth and migration by promoting AEG-1-mediated signaling.
    Li Q, Wang M, Wang N, Wang J, Qi L, Mao P.
    Biomed Pharmacother; 2018 Aug 31; 104():420-426. PubMed ID: 29787989
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
    Chai KM, Wang CY, Liaw HJ, Fang KM, Yang CS, Tzeng SF.
    Oncotarget; 2014 Nov 15; 5(21):10901-15. PubMed ID: 25337721
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression.
    Wu Y, Yao Y, Yun Y, Wang M, Zhu R.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31409725
    [Abstract] [Full Text] [Related]

  • 16. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
    Zhang X, Yu J, Zhao C, Ren H, Yuan Z, Zhang B, Zhuang J, Wang J, Feng B.
    Biomed Pharmacother; 2019 Jan 30; 109():2192-2202. PubMed ID: 30551476
    [Abstract] [Full Text] [Related]

  • 17. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
    Liao Y, Shen L, Zhao H, Liu Q, Fu J, Guo Y, Peng R, Cheng L.
    J Cell Biochem; 2017 Jul 30; 118(7):1889-1899. PubMed ID: 28121023
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294.
    Hua L, Huang L, Zhang X, Feng H.
    J Biosci; 2020 Jul 30; 45():. PubMed ID: 32975228
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.
    Zhu D, Tu M, Zeng B, Cai L, Zheng W, Su Z, Yu Z.
    Cancer Med; 2017 Feb 30; 6(2):452-462. PubMed ID: 28064447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.